ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alaninate CAS:211915-84-3
![ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alaninate CAS:211915-84-3 Featured Image](https://cdnus.globalso.com/puyerinternationalgroup/373.png)
Product Detail
Name: ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alaninate
Feature:
Anticoagulant drugs; Intermediate of the raw material drug dabigatran ester for reducing the risk of stroke and systemic embolism in patients with non valvular atrial fibrillation; Dabigatran intermediate; It is a novel synthetic direct thrombin inhibitor, a precursor drug of dabigatran, and a non peptide thrombin inhibitor.
Composition:
Assay: 99%
Appearance: White powder
CAS No. 211915-84-3
Packing: 25kg
Shelf Life: 2 years
Storage: Store in cool and dry area
Certification:ISO.
![1,5-Diazabicyclo[4.3.0]non-5-ene CAS:3001-72-7](https://cdnus.globalso.com/puyerinternationalgroup/1825-300x300.png)
